expert shares main takeaway for phase iii tags trial in patients with gastric/gej cancer
Published 5 years ago • 93 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
2:21
phase iii tags trial
-
0:54
rationale for using tas-102 in patients with gastric cancer
-
2:54
phase 3 select trial overview
-
3:58
what early phase gastric cancer trials are showing promise?
-
2:21
updated results by duration of prior cdk4/6i in the met setting of the phase iii emerald trial
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
58:58
clinical trial updates webinar (replay) for gastroesophageal cancer patients
-
29:14
keynote lecture 3: carcinogenesis and molecular events in gastric cancer
-
3:44
molecular testing in metastatic gastric/gej cancer
-
2:47
operable gastrointestinal tumors: clinical trial conversation
-
4:50
cancer clinical trials: part 2 - clinical trial phases
-
1:29
interplay between the hgfc-met and hedgehog pathways and implications for cancer treatment
-
2:12
clinical trials investigating immunotherapy for gastric cancer
-
34:31
chair's take: her2-targeted and other agents for gastric cancer
-
42:25
debbie's dream foundation curing stomach cancer - clinical trials for the cancer patient webinar
-
1:08:15
clinical trials updates for gastric cancer patients webinar
-
53:16
mitigating risk: adhering to the standard of care sd 480p